Research Associate I - Lymphoma Biology jobs in United States
cer-icon
Apply on Employer Site
company-logo

City of Hope · 4 weeks ago

Research Associate I - Lymphoma Biology

City of Hope is at the forefront of groundbreaking research, aiming to make a difference in the fight against cancer and other life-threatening illnesses. The Research Associate I will support lymphoma research by performing laboratory experiments, technical procedures, and data management tasks to advance the understanding of lymphoma biology and therapeutics.

AssociationEducationHealth Care
check
Comp. & Benefits

Responsibilities

Utilize laboratory equipment and established protocols to perform a variety of research experiments, including mammalian cell culture, nucleic acid/protein extraction, PCR, and related assays. Record and validate results for accuracy and completeness
Assist with the maintenance, organization, and quality control of research databases, including sample tracking, experimental metadata, and project-related datasets
Conduct molecular biology techniques such as DNA/RNA extraction, cDNA synthesis, gel electrophoresis, and preparation of samples for sequencing or downstream analysis
Perform routine cell line work, including thawing, expansion, authentication, and cryopreservation
Write and update standard operating procedures (SOPs), experimental reports, and laboratory documentation

Qualification

Mammalian cell cultureRNA/DNA extractionMolecular biology techniquesFlow cytometryDatabase managementStandard operating proceduresLaboratory documentation

Required

Bachelor's degree in biological sciences
0-2 years of research/laboratory experience

Preferred

Bachelor's degree in biology, molecular biology, biochemistry, or a related field
Prior experience with mammalian cell culture, sterile technique, RNA/DNA extraction, flow cytometry, and handling of cell lines

Benefits

Comprehensive Benefits

Company

City of Hope

company-logo
City of Hope is a cancer research and treatment non-profit organization specializing in diabetes and other life-threatening illnesses.

Funding

Current Stage
Late Stage
Total Funding
$10.3M
Key Investors
California Institute for Regenerative Medicine
2024-05-20Grant· $5.4M
2022-02-22Grant· $4.9M

Leadership Team

leader-logo
Samuel Lau
Vice President Marketing & Digital Communications
linkedin
leader-logo
Alan H. Bryce
Chief Clinical Officer
linkedin
Company data provided by crunchbase